<!DOCTYPE html>
<html lang="en" data-theme="light">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Autonomic Nervous System - Pharmacology and Pharmacotherapeutics</title>
    
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&family=Source+Serif+4:opsz,wght@8..60,400;8..60,600&display=swap" rel="stylesheet">
    
    <link rel="stylesheet" href="../styles/main.css">
    
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams'
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <a href="#main-content" class="skip-link">Skip to main content</a>
    
    <div class="reading-progress-container">
        <div class="reading-progress-bar" id="reading-progress"></div>
    </div>

    <button class="theme-toggle" id="theme-toggle" aria-label="Toggle dark mode">
        <span class="theme-toggle-icon light-icon">‚òÄÔ∏è</span>
        <span class="theme-toggle-icon dark-icon">üåô</span>
    </button>

    <!-- Floating Table of Contents -->
    <div class="floating-toc" id="floating-toc">
        <div class="floating-toc-header">
            <span>üìë</span>
            <span>Contents</span>
        </div>
        <ul class="floating-toc-list">
            <!-- JS will populate this -->
        </ul>
    </div>

    <div class="page-wrapper">
        <div class="container">
            <article class="document-article">
                <header class="document-header">
                    <div class="header-badge">
                        <span>‚ö°</span>
                        <span>Section IV</span>
                    </div>
                    <h1 class="document-title">Autonomic Nervous System</h1>
                    <div class="title-meta">
                        <div class="meta-item">
                            <span>üìö</span>
                            <span>Chapters 17-22</span>
                        </div>
                        <div class="meta-item">
                            <span>‚è±Ô∏è</span>
                            <span>150 min read</span>
                        </div>
                    </div>
                </header>

                <main id="main-content" class="content-wrapper">
                    <!-- START: Chapter 17 -->
                    <section class="content-section" id="chapter-17">
                        <div class="section-header">
                            <div class="section-number">17</div>
                            <h2 class="section-title">
                                <span class="title-icon">üåê</span>
                                General Considerations
                            </h2>
                        </div>

                        <div class="content-card">
                            <p>The <strong>Autonomic Nervous System (ANS)</strong> is independent of volitional control. It innervates the heart, the smooth muscles, the glands and the viscera. It comprises the <strong>parasympathetic (cholinergic)</strong>, the <strong>sympathetic (adrenergic)</strong> and the <strong>enteric nervous systems</strong>.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251214-a1c96730.jpeg" 
                                         alt="Sites of release of neurohumoral transmitters" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 17.1: Schematic representation of the sites of release of neurohumoral transmitters acetylcholine (ACh) and noradrenaline.</figcaption>
                            </figure>

                            <h3>Divisions</h3>
                            <ul>
                                <li><strong>Parasympathetic:</strong> Craniosacral outflow. Supplies motor fibres to smooth muscle, glands, heart and viscera. Participates in tissue building.</li>
                                <li><strong>Sympathetic:</strong> Thoracolumbar outflow ($\mathrm{T}_1$ to $\mathrm{L}_2$). Prepares body for 'flight or fight' (stress response).</li>
                                <li><strong>Enteric (ENS):</strong> Highly organised neurons in the wall of GI tract (Myenteric and Submucosal plexuses). Controls GI motility and secretions.</li>
                            </ul>

                            <h3>Neurohumoral Transmission</h3>
                            <p><strong>Acetylcholine (ACh)</strong> acts as the transmitter at:</p>
                            <ul>
                                <li>All autonomic ganglia (Sympathetic and Parasympathetic).</li>
                                <li>Postganglionic parasympathetic nerve endings.</li>
                                <li>Sympathetic postganglionic nerve endings supplying sweat glands.</li>
                                <li>Somatic motor nerve endings (Skeletal muscle).</li>
                                <li>Adrenal medulla.</li>
                            </ul>

                            <p><strong>Noradrenaline (NA)</strong> is the transmitter at postganglionic sympathetic nerve endings.</p>
                            
                            <p><strong>Dopamine (DA)</strong> is a transmitter in the basal ganglia, limbic system and CTZ.</p>

                            <div class="callout callout--info">
                                <div class="callout-header">
                                    <span class="callout-icon">üîÑ</span>
                                    <h4 class="callout-title">Synthesis and Metabolism</h4>
                                </div>
                                <div class="callout-content">
                                    <p><strong>ACh:</strong> Synthesised from Choline + Acetyl CoA by <em>Choline Acetyl Transferase</em>. Hydrolysed by <em>Cholinesterase</em> (True and Pseudo).</p>
                                    <p><strong>Catecholamines:</strong> Tyrosine $\to$ DOPA $\to$ Dopamine $\to$ Noradrenaline $\to$ Adrenaline. Metabolised by <strong>MAO</strong> (intracellular) and <strong>COMT</strong> (extracellular). Major inactivation mechanism is <strong>Uptake-1</strong> (reuptake into nerve terminal).</p>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 17 -->

                    <!-- START: Chapter 18 -->
                    <section class="content-section" id="chapter-18">
                        <div class="section-header">
                            <div class="section-number">18</div>
                            <h2 class="section-title">
                                <span class="title-icon">‚ö°</span>
                                Adrenergic Agonists and Antagonists
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Adrenergic Receptors</h3>
                            <p>Classified by Ahlquist into Alpha ($\alpha$) and Beta ($\beta$) receptors.</p>
                            
                            <div class="table-responsive">
                                <table class="comparison-table">
                                    <caption>Table 18.2: Drugs acting on adrenergic receptor subtypes</caption>
                                    <thead>
                                        <tr>
                                            <th>Receptor</th>
                                            <th>Agonists</th>
                                            <th>Antagonists</th>
                                            <th>Primary Location/Function</th>
                                        </tr>
                                    </thead>
                                    <tbody>
                                        <tr>
                                            <td><strong>Alpha 1 ($\alpha_1$)</strong></td>
                                            <td>Phenylephrine, Methoxamine</td>
                                            <td>Prazosin, Terazosin</td>
                                            <td>Postsynaptic (Vessels - Constriction)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Alpha 2 ($\alpha_2$)</strong></td>
                                            <td>Clonidine, Methyldopa</td>
                                            <td>Yohimbine</td>
                                            <td>Presynaptic (Inhibits NA release), Brain (Hypotension)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Beta 1 ($\beta_1$)</strong></td>
                                            <td>Dobutamine</td>
                                            <td>Atenolol, Metoprolol</td>
                                            <td>Heart (Rate/Force $\uparrow$), Kidney (Renin $\uparrow$)</td>
                                        </tr>
                                        <tr>
                                            <td><strong>Beta 2 ($\beta_2$)</strong></td>
                                            <td>Salbutamol, Terbutaline</td>
                                            <td>Butoxamine (No clinical use)</td>
                                            <td>Bronchi/Uterus/Vessels (Relaxation)</td>
                                        </tr>
                                    </tbody>
                                </table>
                            </div>

                            <h3>Catecholamines</h3>
                            <p><strong>Adrenaline (Epinephrine):</strong> Stimulates $\alpha$ and $\beta$ receptors. Used in Anaphylaxis (Drug of choice), Cardiac arrest, Bronchial asthma (acute), with Local anaesthetics.</p>
                            <p><strong>Noradrenaline (Norepinephrine):</strong> Acts mainly on $\alpha$ and $\beta_1$ receptors (weak on $\beta_2$). Powerful vasoconstrictor. Used in Shock.</p>
                            <p><strong>Isoprenaline:</strong> Non-selective $\beta$ agonist. Powerful cardiac stimulant and bronchodilator. Used in Heart block.</p>
                            <p><strong>Dopamine:</strong> Acts on $D_1$ (Renal vasodilation), $\beta_1$ (Cardiac stimulation) and $\alpha_1$ (Vasoconstriction) receptors depending on dose. Used in Shock (Cardiogenic/Septic).</p>
                            <p><strong>Dobutamine:</strong> Selective $\beta_1$ agonist. Increases force of contraction without significant tachycardia. Used in CHF.</p>

                            <figure class="content-figure" data-lightbox="true">
                                <div class="figure-image-wrapper">
                                    <img src="../assets/images/image-20251214-60528c2d.jpeg" 
                                         alt="Effect of Catecholamines on BP" 
                                         class="figure-image"
                                         loading="lazy">
                                    <div class="figure-overlay">
                                        <span class="overlay-icon">üîç</span>
                                        <span class="overlay-text">Click to enlarge</span>
                                    </div>
                                </div>
                                <figcaption class="figure-caption">Fig. 18.2: Effect of Adrenaline, Noradrenaline, Ephedrine, and Isoprenaline on blood pressure.</figcaption>
                            </figure>

                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">üí°</span>
                                    <h4 class="callout-title">Dale's Vasomotor Reversal</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Adrenaline normally causes a rise in BP ($\alpha$ effect). After an $\alpha$-blocker (e.g., ergot), Adrenaline produces a fall in BP because only the $\beta_2$ (vasodilator) action manifests. This is Dale's reversal.</p>
                                </div>
                            </div>

                            <h3>Non-catecholamines</h3>
                            <p>Effective orally, longer duration, cross BBB.</p>
                            <ul>
                                <li><strong>Ephedrine:</strong> Indirectly acting (releases NA) + Direct action. Used in Asthma, Hypotension.</li>
                                <li><strong>Amphetamine:</strong> CNS stimulant. Releases NA/DA. Used in Narcolepsy, ADHD. High abuse potential.</li>
                                <li><strong>Nasal Decongestants:</strong> Phenylephrine, Xylometazoline, Oxymetazoline ($\alpha$ agonists).</li>
                            </ul>

                            <h3>Adrenergic Antagonists</h3>
                            <h4>Alpha Blockers</h4>
                            <ul>
                                <li><strong>Non-selective:</strong> Phenoxybenzamine (Irreversible), Phentolamine. Used in Pheochromocytoma.</li>
                                <li><strong>Selective $\alpha_1$ blockers:</strong> Prazosin, Terazosin, Tamsulosin. Used in Hypertension, Benign Prostatic Hyperplasia (BPH).</li>
                            </ul>

                            <h4>Beta Blockers</h4>
                            <ul>
                                <li><strong>Non-selective:</strong> Propranolol, Timolol, Nadolol.</li>
                                <li><strong>Cardioselective ($\beta_1$):</strong> Atenolol, Metoprolol, Bisoprolol, Esmolol. Safer in asthma/diabetes.</li>
                                <li><strong>With $\alpha$ blocking activity:</strong> Labetalol, Carvedilol.</li>
                            </ul>
                            <p><strong>Uses:</strong> Hypertension, Angina, MI, Arrhythmias, Heart Failure, Glaucoma (Timolol), Thyrotoxicosis, Anxiety, Migraine prophylaxis.</p>
                        </div>
                    </section>
                    <!-- END: Chapter 18 -->

                    <!-- START: Chapter 19 -->
                    <section class="content-section" id="chapter-19">
                        <div class="section-header">
                            <div class="section-number">19</div>
                            <h2 class="section-title">
                                <span class="title-icon">üçÑ</span>
                                Cholinergic Drugs
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Choline Esters & Alkaloids</h3>
                            <p><strong>Acetylcholine:</strong> Not used clinically (rapid hydrolysis). Two types of actions: Muscarinic (blocked by atropine) and Nicotinic.</p>
                            <p><strong>Bethanechol:</strong> Muscarinic selective. Resistant to cholinesterase. Used for Post-op urinary retention, Paralytic ileus.</p>
                            <p><strong>Pilocarpine:</strong> Alkaloid. Miotic. Used in Glaucoma (opens drainage angle).</p>

                            <h3>Anticholinesterases (Anti-ChE)</h3>
                            <p>Inhibit cholinesterase enzyme $\to$ Accumulation of ACh.</p>
                            
                            <h4>Reversible</h4>
                            <ul>
                                <li><strong>Physostigmine:</strong> Crosses BBB (Tertiary amine). Used in Glaucoma, Atropine poisoning.</li>
                                <li><strong>Neostigmine:</strong> No CNS entry (Quaternary). Direct muscle action. Used in Myasthenia Gravis, Curare poisoning, Post-op ileus/retention.</li>
                                <li><strong>Pyridostigmine:</strong> Longer acting. Preferred in Myasthenia.</li>
                                <li><strong>Edrophonium:</strong> Very short acting. Diagnostic test for Myasthenia.</li>
                                <li><strong>Donepezil, Rivastigmine:</strong> Cerebroselective. Used in Alzheimer's disease.</li>
                            </ul>

                            <h4>Irreversible (Organophosphates)</h4>
                            <p>DFP, Parathion, Malathion (Insecticides), Nerve gases. Phosphorylate the enzyme irreversibly.</p>

                            <div class="callout callout--warning">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ò†Ô∏è</span>
                                    <h4 class="callout-title">Organophosphorus Poisoning Treatment</h4>
                                </div>
                                <div class="callout-content">
                                    <ul>
                                        <li>Decontamination (wash skin/eyes).</li>
                                        <li><strong>Atropine:</strong> Drug of choice (2 mg IV every 10 min) till pupils dilate/secretions dry (atropinization). Blocks muscarinic effects.</li>
                                        <li><strong>Oximes (Pralidoxime/PAM):</strong> Cholinesterase reactivators. Effective only if given early (before enzyme aging). Relieve neuromuscular paralysis.</li>
                                        <li>Supportive care (Ventilation).</li>
                                    </ul>
                                </div>
                            </div>
                        </div>
                    </section>
                    <!-- END: Chapter 19 -->

                    <!-- START: Chapter 20 -->
                    <section class="content-section" id="chapter-20">
                        <div class="section-header">
                            <div class="section-number">20</div>
                            <h2 class="section-title">
                                <span class="title-icon">üëÅÔ∏è</span>
                                Muscarinic Receptor Blocking Drugs
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Atropine (Belladonna Alkaloid)</h3>
                            <p>Competitive antagonist of ACh at muscarinic receptors.</p>
                            <p><strong>Actions:</strong></p>
                            <ul>
                                <li><strong>Secretions:</strong> Decreases salivary, bronchial, sweat (dry mouth, dry skin).</li>
                                <li><strong>Eye:</strong> Mydriasis (pupil dilation), Cycloplegia (paralysis of accommodation), Increases IOP (dangerous in narrow angle glaucoma).</li>
                                <li><strong>GI/GU:</strong> Antispasmodic (relaxes smooth muscle), Urinary retention.</li>
                                <li><strong>Heart:</strong> Tachycardia (blocks vagal tone).</li>
                                <li><strong>CNS:</strong> Mild stimulation (toxic doses $\to$ delirium).</li>
                            </ul>

                            <p><strong>Uses:</strong> Preanaesthetic medication, Organophosphorus poisoning, Heart block, Mydriatic (refraction testing), Colic.</p>

                            <div class="callout callout--danger">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ö†Ô∏è</span>
                                    <h4 class="callout-title">Atropine Poisoning</h4>
                                </div>
                                <div class="callout-content">
                                    <p>Symptoms: "Dry as a bone, blind as a bat, red as a beet, mad as a hatter, hot as a hare".<br>
                                    Treatment: <strong>Physostigmine</strong> (crosses BBB).</p>
                                </div>
                            </div>

                            <h3>Synthetic Substitutes</h3>
                            <ul>
                                <li><strong>Mydriatics:</strong> Homatropine, Tropicamide (shorter acting).</li>
                                <li><strong>Antispasmodics:</strong> Dicyclomine, Propantheline, Hyoscine butylbromide.</li>
                                <li><strong>Bronchodilators:</strong> Ipratropium, Tiotropium (Inhalational).</li>
                                <li><strong>Vesicoselective (For Overactive Bladder):</strong> Oxybutynin, Tolterodine, Solifenacin (M3 selective).</li>
                                <li><strong>Antiparkinsonian:</strong> Trihexyphenidyl (Benzhexol).</li>
                            </ul>
                        </div>
                    </section>
                    <!-- END: Chapter 20 -->

                    <!-- START: Chapter 21 -->
                    <section class="content-section" id="chapter-21">
                        <div class="section-header">
                            <div class="section-number">21</div>
                            <h2 class="section-title">
                                <span class="title-icon">üö¨</span>
                                Ganglion Stimulating and Blocking Drugs
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>Nicotine</h3>
                            <p>Stimulates both sympathetic and parasympathetic ganglia (Nicotinic $N_n$ receptors). Complex effects depending on dominant tone. High doses cause depolarization block.</p>
                            <p><strong>Tobacco Smoking:</strong> Associated with Cancer (lung, oral), COPD, IHD, Peripheral vascular disease.</p>
                            <p><strong>Therapy for Dependence:</strong> Nicotine replacement (gum, patch), Bupropion, Varenicline (partial agonist).</p>

                            <h3>Ganglion Blockers</h3>
                            <p>Hexamethonium, Mecamylamine, Trimethaphan. Block both sympathetic and parasympathetic ganglia. <strong>Pharmacological sympathectomy + parasympathectomy.</strong></p>
                            <p><strong>Effects:</strong> Hypotension (postural), Tachycardia, Mydriasis, Dry mouth, Constipation, Urinary retention. <strong>Obsolete</strong> clinically except Trimethaphan (rarely used for controlled hypotension).</p>
                        </div>
                    </section>
                    <!-- END: Chapter 21 -->

                    <!-- START: Chapter 22 -->
                    <section class="content-section" id="chapter-22">
                        <div class="section-header">
                            <div class="section-number">22</div>
                            <h2 class="section-title">
                                <span class="title-icon">üí™</span>
                                Skeletal Muscle Relaxants
                            </h2>
                        </div>

                        <div class="content-card">
                            <h3>I. Peripherally Acting (Neuromuscular Blockers)</h3>
                            <p>Used in anaesthesia for muscle relaxation.</p>
                            
                            <h4>A. Non-depolarizing (Competitive) Blockers</h4>
                            <p><strong>d-Tubocurarine</strong> (prototype), <strong>Pancuronium, Vecuronium, Atracurium, Rocuronium</strong>.</p>
                            <p><strong>Mechanism:</strong> Competitively block Nicotinic ($N_m$) receptors at motor end plate.</p>
                            <p><strong>Reversal:</strong> Neostigmine (increases ACh which displaces blocker) + Atropine.</p>
                            <div class="callout callout--note">
                                <div class="callout-header">
                                    <span class="callout-icon">‚ÑπÔ∏è</span>
                                    <h4 class="callout-title">Drug Features</h4>
                                </div>
                                <div class="callout-content">
                                    <ul>
                                        <li><strong>Atracurium:</strong> Hofmann elimination (safe in renal/hepatic failure).</li>
                                        <li><strong>Mivacurium:</strong> Short acting. Metabolised by plasma cholinesterase.</li>
                                    </ul>
                                </div>
                            </div>

                            <h4>B. Depolarizing Blockers</h4>
                            <p><strong>Succinylcholine (Suxamethonium)</strong>.</p>
                            <p><strong>Mechanism:</strong> Persistent depolarization of motor end plate (Phase I block). Initial fasciculations $\to$ Paralysis.</p>
                            <p><strong>Characteristics:</strong> Short acting (5 mins) due to hydrolysis by pseudocholinesterase. Not reversed by neostigmine.</p>
                            <p><strong>Adverse Effects:</strong> Muscle pain, Hyperkalemia (danger in burns/trauma), malignant hyperthermia, succinylcholine apnea (in atypical pseudocholinesterase).</p>

                            <h3>II. Centrally Acting Muscle Relaxants</h3>
                            <p>Reduce muscle tone by action in CNS. Used for spasticity and muscle spasms.</p>
                            <ul>
                                <li><strong>Diazepam:</strong> Facilitates GABA.</li>
                                <li><strong>Baclofen:</strong> $\mathrm{GABA}_{\mathrm{B}}$ agonist. Used in multiple sclerosis, spinal injuries.</li>
                                <li><strong>Tizanidine:</strong> Central $\alpha_2$ agonist.</li>
                                <li><strong>Methocarbamol, Chlorzoxazone:</strong> For acute muscle spasms.</li>
                            </ul>

                            <h3>III. Directly Acting</h3>
                            <p><strong>Dantrolene:</strong> Inhibits calcium release from sarcoplasmic reticulum. Drug of choice for <strong>Malignant Hyperthermia</strong>. Also used in spasticity.</p>
                            
                            <p><strong>Botulinum Toxin A:</strong> Inhibits ACh release. Used for local dystonias, cosmetic wrinkles (Botox).</p>
                        </div>
                    </section>
                    <!-- END: Chapter 22 -->

                    <aside class="key-points-section" role="region" aria-labelledby="key-points-title">
                        <div class="key-points-wrapper">
                            <div class="key-points-header">
                                <span class="key-points-icon">‚≠ê</span>
                                <h3 id="key-points-title" class="key-points-title">Section IV Key Points</h3>
                            </div>
                            <ul class="key-points-list">
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Adrenaline</strong> is the drug of choice for anaphylactic shock ($\alpha$ + $\beta$ action).</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Beta-blockers</strong> are cardioprotective but contraindicated in asthma and heart block.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Atropine</strong> is specific antidote for organophosphorus poisoning.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Neostigmine</strong> reverses non-depolarizing neuromuscular block but not succinylcholine block.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Succinylcholine</strong> is short-acting but can cause apnea in patients with atypical pseudocholinesterase.</p>
                                </li>
                                <li class="key-point-item">
                                    <span class="point-marker">‚úì</span>
                                    <p><strong>Pralidoxime</strong> reactivates cholinesterase if given early in OP poisoning.</p>
                                </li>
                            </ul>
                        </div>
                    </aside>
                </main>

                <nav class="document-nav">
                    <div class="nav-container">
                        <a href="section-03.html" class="nav-button nav-button--large nav-button--previous">
                            <div class="nav-label">Previous</div>
                            <div class="nav-title">Section III: Local Anaesthetics</div>
                        </a>
                        
                        <div class="document-progress">
                            <div class="progress-indicator">
                                <span>4</span>
                                <span class="progress-separator">/</span>
                                <span>16</span>
                            </div>
                        <a href="../index.html" class="nav-button nav-button--large">
                            <div class="nav-label">Go to</div>
                            <div class="nav-title">Index</div>
                        </a>
                            <div class="progress-bar-container">
                                <div class="progress-bar-fill" style="width: 25%;"></div>
                            </div>
                            <div class="progress-label">Section 4 of 16</div>
                        </div>
                        
                        <a href="section-05.html" class="nav-button nav-button--large nav-button--next">
                            <div class="nav-label">Next</div>
                            <div class="nav-title">Section V: Biogenic Amines</div>
                        </a>
                    </div>
                </nav>
            </article>
        </div>
    </div>

    <!-- Lightbox Modal -->
    <div class="lightbox-modal" id="lightbox-modal" role="dialog" aria-modal="true" aria-label="Image viewer" hidden>
        <div class="lightbox-backdrop"></div>
        <div class="lightbox-content">
            <button class="lightbox-close" aria-label="Close image viewer">√ó</button>
            <img class="lightbox-image" src="" alt="">
            <p class="lightbox-caption"></p>
        </div>
    </div>

    <script src="../js/theme.js"></script>
    <script src="../js/navigation.js"></script>
    <script src="../js/interactions.js"></script>
</body>
</html>